Pregnancy Experiences of Women With Rheumatic Diseases During the COVID-19 Pandemic
Study authors evaluated the pregnancy experiences of women with rheumatic disease during the COVID-19 pandemic.
All articles by Emily Pond
Increased Mortality Risk Among Patients With Rare Autoimmune Rheumatic Diseases During the COVID-19 Pandemic
Researchers quantified the risk for death among patients with rare autoimmune rheumatic diseases vs the general population during the COVID-19 pandemic.
Methotrexate Discontinuation May Improve Influenza Vaccine Response During the COVID-19 Pandemic
Study authors evaluated the effects of methotrexate discontinuation on influenza vaccine response during the COVID-19 pandemic.
Hepatocellular Carcinoma May Present at Earlier Stage of Liver Disease in Black Patients With HCV
Investigators evaluated the incidence of HCC in the absence of cirrhosis in Black patients with HCV.
Significant Decline in IBD Diagnoses and Related Procedures Seen During COVID-19 Pandemic in the Netherlands
Investigators compared the rates of inflammatory bowel disease (IBD) diagnoses made and IBD-related procedures performed during the COVID-19 pandemic with pre-pandemic rates.
Case Study Reports First Known Case of Neutrophilic Arterial Vasculitis in COVID-19
Authors of this case study reported the first case of neutrophilic arterial vasculitis in COVID-19.
Rectal Shedding of SARS-CoV-2 May Persist for Up to 7 Weeks
The goal of this study was to examine the time sequences of oral and fecal viral shedding in patients with coronavirus disease 2019 (COVID-19).
COVID-19 Pandemic Associated with Acute Stress, Depressive Symptoms in Residents of the United States
While the COVID-19 pandemic is a stress-inducing event, published empirical studies about mental health consequences are rare.
COVID-19-Related Delays in CRC Screening Expected to Cause Increased Mortality
The potential consequences of delaying CRC screening due to the COVID-19 pandemic may lead to an increase in CRC mortality.
Serious Infection Risk Not Significantly Higher With Denosumab vs Alendronate in Osteoporosis
Researchers assessed the serious infection risk for denosumab vs alendronate in real-world practice.
-
Loading...
-
Loading...
Next post in General Infectious Disease
